Component: (Network and Table)
Network
00300 - Statement - Consolidated Statements of Cash Flows
(http://www.carlisle.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000790051 (http://www.sec.gov/CIK)
Consolidated Statements of Cash FlowsPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Consolidated Statements of Cash Flows
 
 
 
Operating activities
 
 
 
Net income
250,100,000  
319,700,000  
251,300,000  
Reconciliation of net income to cash flows provided by operating activities:
 
 
 
Depreciation
75,100,000  
73,500,000  
64,700,000  
Amortization
62,700,000  
55,800,000  
39,300,000  
Impairment charges
141,500,000  
  
Stock-based compensation, net of tax benefit
(2,600,000) 
2,700,000  
3,300,000  
Deferred taxes
(25,000,000) 
(15,800,000) 
(9,900,000) 
Other operating activities, net
(6,000,000) 
(1,300,000) 
(2,400,000) 
Changes in assets and liabilities, excluding effects of acquisitions:
 
 
 
Receivables
300,000  
(11,800,000) 
(18,100,000) 
Inventories
(12,200,000) 
23,000,000  
(27,700,000) 
Prepaid expenses and other assets
(9,200,000) 
6,700,000  
(5,500,000) 
Accounts payable
21,600,000  
(2,900,000) 
(5,100,000) 
Accrued expenses and deferred revenues
34,800,000  
78,400,000  
14,500,000  
Other long-term liabilities
100,000  
1,200,000  
(8,500,000) 
Net cash provided by operating activities
531,200,000  
 
529,200,000  
 
295,900,000  
 
Investing activities
 
 
 
Capital expenditures
(108,800,000) 
(72,100,000) 
(118,800,000) 
Acquisitions, net of cash acquired
(185,500,000) 
(598,900,000) 
(194,000,000) 
Other investing activities, net
900,000  
200,000  
15,000,000  
Net cash used in investing activities
(293,400,000) 
 
(670,800,000) 
 
(297,800,000) 
 
Financing activities
 
 
 
Repayments of borrowings
(150,000,000) 
(1,500,000) 
(1,500,000) 
Dividends paid
(84,500,000) 
(72,300,000) 
(61,200,000) 
Proceeds from exercise of stock options, net
48,400,000  
39,400,000  
42,500,000  
Repurchases of common stock
(75,000,000) 
(137,200,000) 
 
Other financing activities, net
 
(1,400,000) 
 
Net cash used in financing activities
(261,100,000) 
 
(173,000,000) 
 
(20,200,000) 
 
Effect of foreign currency exchange rate changes on cash and cash equivalents
(2,100,000) 
(5,500,000) 
(1,600,000) 
Change in cash and cash equivalents
(25,400,000) 
 
(320,100,000) 
 
(23,700,000) 
 
Cash and cash equivalents
 
 
 
Beginning of period
410,700,000  
730,800,000  
754,500,000  
End of period
385,300,000  
 
410,700,000  
 
730,800,000